Rick,
Sure you saw this, any thoughts?
biowa
----------------
Therion Biologics and National Cancer
Institute Initiate Phase II Trial of Novel
Melanoma Vaccines -- Newest vaccines join
Therion's cancer portfolio with additional <>
CAMBRIDGE, Mass., Oct. 18 /PRNewswire/
...Therion's tyrosinase vaccines will be tested alone and in conjunction with interleukin-2 (IL-2), a known immunostimulatory molecule, to evaluate IL-2's potential to enhance the immune response. The study is expected to enroll up to 73 patients...
...Steven A. Rosenberg, M.D., Chief of the NCI Surgery Branch, will serve as associate investigator... |
